- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07312344
Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals (Exercise)
December 16, 2025 updated by: Mahidol University
Exploring the Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals on Lymphangiogenesis
This project aims to study the effect of exercise in the obesity/overweight on the changes of physical fitness and blood components.
This will provide novel knowledge for medical staffs, researchers, or companies developing alternative strategies for treating obesity/overweight, including drug development and health promotion project to delay or prevent the onset of the disease.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Onaong Mee-inta, Ph.D.
- Phone Number: (66)619922941
- Email: onanong.mee@mahidol.ac.th
Study Contact Backup
- Name: Phunsuk Kantha, Ph.D.
- Phone Number: (66)932951646
- Email: phunsuk.kan@mahidol.ac.th
Study Locations
-
-
-
Mueang Samut Prakan, Thailand, 10540
- Recruiting
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male or female individuals aged between 25-45 years
- Thai nationality
- Ability to walk or perform daily activities independently, without the use of an assistive device
- Body mass index (BMI) between 25-35 kg/m²
Low physical activity levels or sedentary lifestyle based on the World Health Organization 2020
- The levels of moderate-intensity physical activity < 150-300 minutes per week or the levels of vigorous-intensity physical activity < 75-150 minutes per week
- Moderate-intensity physical activity: fast walking and bicycling. Vigorous-intensity physical activity: running, aerobic dance, and swimming All participants are required to meet all inclusion criteria to be eligible for the research project.
Exclusion Criteria:
- Smoking, substance abuse, or alcohol addiction
- History of respiratory diseases, such as asthma, emphysema, or chronic obstructive pulmonary disease
- History of cardiovascular diseases, such as coronary heart disease, aortic disease, arrhythmia, or deep vein thrombosis
- History of high blood pressure (hypertension)
- History of vestibular system diseases, such as Meniere's disease or otitis media
- History of neurological disease, such as severe Parkinson's disease or stroke
- History of previous lower limb surgery, such as hip, knee, or ankle replacement
- History of musculoskeletal diseases, such as severe osteoarthritis
- History of severe brain disease, such as dementia
- Severe visual or hearing impairment
- Have a cognitive and comprehensive impairment and unable to complete the intervention
- Have high physical activity or regularly exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-intensity interval training exercise
High-intensity interval training exercise 3 days per week for 6 weeks
|
High-intensity interval training exercise using 65% to 80% of heart rate max
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood component assessment
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program within 1 hour)
|
Participant's blood components, e.g.
extracellular vesicles, will be investigated by cell assays and proteomic analysis
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program within 1 hour)
|
|
Foot pressure distribution
Time Frame: 8 times: Day 1 (Before and after HIIT program), Day 4-7 (after HIIT program only), Day 18 (Before and after HIIT program)
|
Foot pressure distribution will be measured using a treadmill (Zebris FDM-T Treadmill System, zebris Medical GmbH, Germany)
|
8 times: Day 1 (Before and after HIIT program), Day 4-7 (after HIIT program only), Day 18 (Before and after HIIT program)
|
|
Facial and abdominal fat thickness measurement
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Facial and abdominal fat thickness and characteristics will be pictured and analyzed using ultrasound imaging
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
VO2max
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
VO2max parameter (ml/kg/min) will be examined using Cardio Pulmonary Exercise Test
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Body composition
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Body composition (%) will be measured by bioelectrical impedance analysis.
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Heart rate
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Heart rate (beat/min) will be measured by pulse oximeters
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Grip strength
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Grip strength (kg) will be measured by hand grip dynamometer
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Leg strength
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Leg strength (kg) will be measured by back-leg-chest dynamometer
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Body weight
Time Frame: Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
Body weight (kg) will be measured by weighing scale
|
Pre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)
|
|
Body height
Time Frame: Pre-training (Day 1 before HIIT program)
|
Body height (cm) will be measured by stadiometer
|
Pre-training (Day 1 before HIIT program)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015 Jun 29;212(7):991-9. doi: 10.1084/jem.20142290. Epub 2015 Jun 15.
- Gremeaux V, Drigny J, Nigam A, Juneau M, Guilbeault V, Latour E, Gayda M. Long-term lifestyle intervention with optimized high-intensity interval training improves body composition, cardiometabolic risk, and exercise parameters in patients with abdominal obesity. Am J Phys Med Rehabil. 2012 Nov;91(11):941-50. doi: 10.1097/PHM.0b013e3182643ce0.
- Ryan BJ, Schleh MW, Ahn C, Ludzki AC, Gillen JB, Varshney P, Van Pelt DW, Pitchford LM, Chenevert TL, Gioscia-Ryan RA, Howton SM, Rode T, Hummel SL, Burant CF, Little JP, Horowitz JF. Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2941-59. doi: 10.1210/clinem/dgaa345.
- Turk Y, Theel W, Kasteleyn MJ, Franssen FME, Hiemstra PS, Rudolphus A, Taube C, Braunstahl GJ. High intensity training in obesity: a Meta-analysis. Obes Sci Pract. 2017 May 29;3(3):258-271. doi: 10.1002/osp4.109. eCollection 2017 Sep.
- He XF, Liu DX, Zhang Q, Liang FY, Dai GY, Zeng JS, Pei Z, Xu GQ, Lan Y. Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice. Front Mol Neurosci. 2017 May 19;10:144. doi: 10.3389/fnmol.2017.00144. eCollection 2017.
- Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015 Jul 16;523(7560):337-41. doi: 10.1038/nature14432. Epub 2015 Jun 1.
- Secker GA, Harvey NL. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels. Dev Dyn. 2015 Mar;244(3):323-31. doi: 10.1002/dvdy.24227. Epub 2014 Dec 4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2025
Primary Completion (Estimated)
January 31, 2026
Study Completion (Estimated)
January 31, 2026
Study Registration Dates
First Submitted
November 30, 2025
First Submitted That Met QC Criteria
December 16, 2025
First Posted (Actual)
December 31, 2025
Study Record Updates
Last Update Posted (Actual)
December 31, 2025
Last Update Submitted That Met QC Criteria
December 16, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MURA2025/678
- 2025/1365 (Registry Identifier: Mahidol University Multi-faculty Cooperative IRB Review)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity & Overweight
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
Clinical Trials on High-intensity interval training exercise on treadmill
-
University of Nove de JulhoCompletedObstructive Sleep Apnea | Obesity, Childhood | BalanceBrazil
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Yasemin ASLAN KELEŞIstanbul University - Cerrahpasa (IUC)CompletedEnd Stage Renal Disease | Exercise, CompulsiveTurkey
-
Arizona State UniversityMayo Clinic; University of AlbertaCompleted
-
Universidad Santo TomasUniversidad Nacional de Colombia; Universidad del RosarioCompletedObesity | Cognitive Function | Motor ActivityColombia
-
Kaohsiung Medical University Chung-Ho Memorial...Ministry of Science and Technology, TaiwanRecruiting
-
Riphah International UniversityRecruiting
-
University of NebraskaNational Institute of General Medical Sciences (NIGMS)Terminated
-
University of AthensUnknown